Cargando…
Evaluation of Perienhancing Area in Differentiation between Glioblastoma and Solitary Brain Metastasis
PURPOSE: Accurate differential diagnosis between glioblastoma and brain metastasis is important. We aimed to differentiate these tumors by evaluation of the perienhancing area. MATERIALS AND METHODS: Thirty patients with glioblastoma and solitary brain metastasis were included. The diameters of peri...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779443/ https://www.ncbi.nlm.nih.gov/pubmed/32986348 http://dx.doi.org/10.31557/APJCP.2020.21.9.2525 |
_version_ | 1783631335090290688 |
---|---|
author | Thammaroj, Jureerat Wongwichit, Nattha Boonrod, Arunnit |
author_facet | Thammaroj, Jureerat Wongwichit, Nattha Boonrod, Arunnit |
author_sort | Thammaroj, Jureerat |
collection | PubMed |
description | PURPOSE: Accurate differential diagnosis between glioblastoma and brain metastasis is important. We aimed to differentiate these tumors by evaluation of the perienhancing area. MATERIALS AND METHODS: Thirty patients with glioblastoma and solitary brain metastasis were included. The diameters of perienhancing and enhancing areas were measured, and the percentage of enhancing area was calculated. We measured Apparent diffusion coefficient (ADC) of perienhancing and enhancing areas. Intratumoral necrotic areas were measured. RESULTS: The enhancing area of glioblastoma was 56.61% and metastasis was 42.55% (p = 0.08). The ADC values of the perienhancing part of GBM was 0.7 and metastasis was 0.79 (p = 0.052). The ADC value of the enhancing part of the GBM was 0.82 and metastasis was 0.8 (p-value = 0.72). The intratumoral necrotic area of glioblastoma (152.25 mm(3)) was higher than in metastasis (0 mm(3)) (p-value = 0.003) with a cutoff area of 11.8 mm(2). CONCLUSION: The ADC values of the perienhancing area were lower in glioblastoma with a near-significant p-value. Other perienhancing parameters demonstrated no significant difference between both tumors. The intratumoral necrotic area of glioblastoma is larger than metastasis. |
format | Online Article Text |
id | pubmed-7779443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | West Asia Organization for Cancer Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-77794432021-01-08 Evaluation of Perienhancing Area in Differentiation between Glioblastoma and Solitary Brain Metastasis Thammaroj, Jureerat Wongwichit, Nattha Boonrod, Arunnit Asian Pac J Cancer Prev Research Article PURPOSE: Accurate differential diagnosis between glioblastoma and brain metastasis is important. We aimed to differentiate these tumors by evaluation of the perienhancing area. MATERIALS AND METHODS: Thirty patients with glioblastoma and solitary brain metastasis were included. The diameters of perienhancing and enhancing areas were measured, and the percentage of enhancing area was calculated. We measured Apparent diffusion coefficient (ADC) of perienhancing and enhancing areas. Intratumoral necrotic areas were measured. RESULTS: The enhancing area of glioblastoma was 56.61% and metastasis was 42.55% (p = 0.08). The ADC values of the perienhancing part of GBM was 0.7 and metastasis was 0.79 (p = 0.052). The ADC value of the enhancing part of the GBM was 0.82 and metastasis was 0.8 (p-value = 0.72). The intratumoral necrotic area of glioblastoma (152.25 mm(3)) was higher than in metastasis (0 mm(3)) (p-value = 0.003) with a cutoff area of 11.8 mm(2). CONCLUSION: The ADC values of the perienhancing area were lower in glioblastoma with a near-significant p-value. Other perienhancing parameters demonstrated no significant difference between both tumors. The intratumoral necrotic area of glioblastoma is larger than metastasis. West Asia Organization for Cancer Prevention 2020-09 /pmc/articles/PMC7779443/ /pubmed/32986348 http://dx.doi.org/10.31557/APJCP.2020.21.9.2525 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Thammaroj, Jureerat Wongwichit, Nattha Boonrod, Arunnit Evaluation of Perienhancing Area in Differentiation between Glioblastoma and Solitary Brain Metastasis |
title | Evaluation of Perienhancing Area in Differentiation between Glioblastoma and Solitary Brain Metastasis |
title_full | Evaluation of Perienhancing Area in Differentiation between Glioblastoma and Solitary Brain Metastasis |
title_fullStr | Evaluation of Perienhancing Area in Differentiation between Glioblastoma and Solitary Brain Metastasis |
title_full_unstemmed | Evaluation of Perienhancing Area in Differentiation between Glioblastoma and Solitary Brain Metastasis |
title_short | Evaluation of Perienhancing Area in Differentiation between Glioblastoma and Solitary Brain Metastasis |
title_sort | evaluation of perienhancing area in differentiation between glioblastoma and solitary brain metastasis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779443/ https://www.ncbi.nlm.nih.gov/pubmed/32986348 http://dx.doi.org/10.31557/APJCP.2020.21.9.2525 |
work_keys_str_mv | AT thammarojjureerat evaluationofperienhancingareaindifferentiationbetweenglioblastomaandsolitarybrainmetastasis AT wongwichitnattha evaluationofperienhancingareaindifferentiationbetweenglioblastomaandsolitarybrainmetastasis AT boonrodarunnit evaluationofperienhancingareaindifferentiationbetweenglioblastomaandsolitarybrainmetastasis |